Clinical Considerations in the Treatment of Acne Vulgaris and Other Inflammatory Skin Disorders: a Status Report
Overview
Affiliations
This article reviews the anti-inflammatory and nonantimicrobial effects of antibiotics in acne and other diseases and examines issues relating to the emergence of decreased bacterial sensitivity to antibiotics and how these issues relate to clinical practice. It includes an overview of the inflammatory activities of some antibiotic agents and their potential for use in various dermatologic and nondermatologic diseases. It demonstrates that P. acnes-resistant organisms may be associated with therapeutic failure in some patients with acne, and that the prudent use of antibiotics is necessary to ensure that we can continue to use these drugs to combat disease effectively. It concludes that there are treatment strategies that can effectively minimize the potential for development of resistant P. acnes organisms.
Del Rosso J J Clin Aesthet Dermatol. 2021; 13(10):45-48.
PMID: 33584958 PMC: 7840093.
Kim H, Park S, Lee G Toxins (Basel). 2019; 11(7).
PMID: 31252651 PMC: 6669657. DOI: 10.3390/toxins11070374.
Synchronizing Pharmacotherapy in Acne with Review of Clinical Care.
Sacchidanand S, Lahiri K, Godse K, Patwardhan N, Ganjoo A, Kharkar R Indian J Dermatol. 2017; 62(4):341-357.
PMID: 28794543 PMC: 5527713. DOI: 10.4103/ijd.IJD_41_17.
Del Rosso J, Webster G, Rosen T, Thiboutot D, Leyden J, Gallo R J Clin Aesthet Dermatol. 2016; 9(4):18-24.
PMID: 27462384 PMC: 4898580.
Baran U, Li Y, Choi W, Kalkan G, Wang R Lasers Surg Med. 2015; 47(3):231-8.
PMID: 25740313 PMC: 4376563. DOI: 10.1002/lsm.22339.